Tavassoli FA, Devilee P: Pathology and Genetics: Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours series - volume IV. Lyon, France: IARC Press-Reference-Cited by-同舟云学术

Tavassoli FA, Devilee P: Pathology and Genetics: Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours series - volume IV. Lyon, France: IARC Press

Published:2004-03-31 Issue:3 Volume:6 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Hanby Andrew M,walker Clare

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr788.pdf

Reference4 articles.

1. Potter CRD, Eechout I, Geerts M-L, Schelfhout A-M, Roels H: Keratinocyte chemotaxis in the pathogenesis of Paget's disease of the breast. Histopathology. 1994, 24: 349-356. 10.1111/j.1365-2559.1994.tb00536.x.

2. Schelfhout VRJ, Coene EDB, Delaey B, Thys S, Page DL, De Potter CR: Pathogenesis of Paget's disease: Epidermal heregulin-a motility factor, and the HER receptor family. JNCI. 2000, 92: 622-628. 10.1093/jnci/92.8.622.

3. Fisher CJ, Hanby AM, Robinson LRR, Millis RR: Mammary hamartoma – a review of 35 cases. Histopathology. 1992, 20: 99-106. 10.1111/j.1365-2559.1992.tb00938.x.

4. Gillett CE, Miles DW, Ryder K, Skilton D, Liebman RD, Springall RJ, Barnes DM, Hanby AM: Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. Journal of Pathology. 2001, 193: 433-41. 10.1002/path.831.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radio-pathological characteristics of primary neuroendocrine breast carcinoma: Series of 4 cases;Radiology Case Reports;2024-12

2. Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study;Pathology - Research and Practice;2024-10

3. Benign Giant Phyllodes Tumours Presenting as Fungating Breast Masses;Cureus;2024-09-03

4. Survival Trends for Uterine Sarcomas from a Tertiary Center: The Oxford Experience;Diseases;2024-09-02

5. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23